Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

Cll Research and Treatment Program, New Hyde Park

University of Virginia School of Medicine Hospital, Charlottesville

The Ohio Sate university, Columbus

University of Wisconsin, Madison

MD Anderson Cancer Center, Houston

Universitatsklinikum Ulm, Klinik fur Innere Medizin II, Ulm

Stanford University School of Medicine, Stanford

New York Presbyterian Hospital/Cornell Medical Center, New York

Oregon Health & Science University, Portland

Hackensack University Medical Center, Hackensack

Klinikum der Universitat Munchen - Campus Grosshadern, München

Oddzail Kliniczny Onkologil, Bydgoszcz

Malopolskie Centrum Medyczne, Krakow

MTZ Clinical Research Sp. z o.o., Warsaw

Centre for Experimental Cancer Medicine, London

Christie Hospital, Manchester

Derriford Hospital, Plymouth

Southampton General Hospital, Southampton